BookMeds

Hyderabad, India Founded: 2014 • Age: 12 yrs Minicorn
Medicines and healthcare products are ordered online from local pharmacies.

About BookMeds

BookMeds is a Healthcare company based in Hyderabad (India) founded in 2014. Medicines and healthcare products are ordered online from local pharmacies. BookMeds has raised $245.28 thousand across 3 funding rounds from investors including Fabella Singapore. BookMeds was last valued at $4.78 million in October 2015. Its Indian entity Zibew E-Commerce Services Private Limited reported revenue of β‚Ή79.9 Lakh. Its focus areas include HealthTech, Healthcare Booking Platforms, Pharmacies and Drugs. Its competitors include Tata 1mg, Truemeds and PharmEasy; 3 of its 3 listed competitors have raised funding.

Company details

Bookmeds Is An Online Healthcare Start-up That Enables Customers To Order Prescriptive And Non-prescriptive Medicines As Well As Surgical Medical Products. Sources Medicines Products From Local Pharmacies. Employs Certified Pharmacists For All Pharmaceutical-related Operations Including Delivery Of Medicines. Offers Cash On Delivery As Well As Online Payment. Used Especially For Life-saving Medicines That Are Not Easily Available. Invoice For The Medicine Is Generated By The Local Pharmacy In The Name Of The End User. Raised 100,000 (inr 6.3m) In Seed Funding From Fabella Singapore , An Investment Firm Founded By Krish Datta, Former President (southeast Asia And Emerging Markets) At Sap. Providing 30 Odd Deliveries A Day, As Of Dec 2014. Currently Catering To Hyderabad.

Key Metrics
  • Annual Revenue
    ₹79.9 Lakh

    FY 2024 · -18% YoY

  • Net Profit
    ₹2.7 Lakh

    FY 2024 · 3% margin

  • EBITDA
    ₹3.9 Lakh

    FY 2024 · 5% margin

  • Total Equity Funding
    $245.28K (USD)

    in 3 rounds

  • Latest Funding Round
    $95.81K (USD), Seed

    Oct 2015

Funding Insights of BookMeds

BookMeds has successfully raised a total of $245.28K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $95.81 thousand completed in October 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $245,284
  • Total Rounds 3
  • Last Round Seed β€” $95,807
  • First Round $100,000

    (Dec 2014)

  • Investors Count 1

All 3 funding rounds of BookMeds with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2015$95,807Seed$4.78MFabella Singapore
–
Feb 2015$49,477Seed–Fabella Singapore
–
Dec 2014$100,000Angel Round$255,029–
–
Valuation history
DateValuationStage
Oct 2015$4.78Mβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $4.78M (Oct 2015). 1 investors in total: 1 institutional.

Investors in BookMeds

BookMeds has secured backing from 1 investor. Prominent investors backing the company include Fabella Singapore.

All
InvestorDescriptionFounded YearDomainLocation
fabellasingapore.tcc.mode
Premium access

Investor details for BookMeds

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Zibew E-Commerce Services Private Limited (BookMeds)

Zibew E-Commerce Services Private Limited is the primary company behind BookMeds. The board of Zibew E-Commerce Services Private Limited currently have 2 directors; the longest-serving is Kouser Banu, appointed in 2013. 2 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Kouser Banu
DIN 06755736
Director24 Dec 201312 yrs 9 moZibew E-Commerce Services Private Limited
Subathra Santhanam
DIN 06762410
Director24 Dec 201312 yrs 9 moZibew E-Commerce Services Private Limited

People of BookMeds

2 people are tracked at BookMeds (2 in leadership).

NameRoleGroup
founderLeadership
Fouzia Shaheen
founderLeadership
Premium access

Complete people profiles for BookMeds

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of BookMeds

Figures of Zibew E-Commerce Services Private Limited, the primary company behind BookMeds, for FY 2024. Revenue was ₹79.9 Lakh (-18% year on year). Net profit was ₹2.7 Lakh (3% margin). EBITDA was ₹3.9 Lakh (5% margin). Revenue has grown at a compounded annual rate of 0% over three years and -7% over five years.

  • ₹79.9 LakhRevenue · FY 2024 · -18% YoY
  • ₹2.7 LakhNet profit · 3% margin
  • ₹3.9 LakhEBITDA · 5% margin
  • ₹3.2 LakhPaid-up capital
  • 0%Revenue CAGR, 3 years
  • -7%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Zibew E-Commerce Services Private Limited are on its company page.

Premium access

Detailed financial statements for BookMeds

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of BookMeds

4 dated milestones of BookMeds across 1 years, from founding to its latest funding, stage changes and deals.

  1. Founded BookMeds is founded.
  2. Funding First funding round of $100K.
  3. Funding Latest funding round, Seed, of $96K.
  4. Milestone Reaches Minicorn status.

Competitors of BookMeds

BookMeds has 3 listed competitors in our database, 3 of them funded. They include Tata 1mg, Truemeds and PharmEasy.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
1mg.com2015Delhi, India$230.8M4,419
Provider of an online pharmacy with doctor listing and teleconsultation services
truemeds.in2019Mumbai, India$112.97M345
Provider of an online pharmacy and telehealth platform
pharmeasy.in2015Mumbai, India$688.41M493
Provider of an online pharmacy and healthcare platforms
Premium access

Detailed competitors of BookMeds

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Digital Health & Telemedicine

3 companies that operate in the same segment as BookMeds (Digital Health & Telemedicine) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of an online pharmacy with doctor listing and teleconsultation services
2015Delhi, Delhi, IndiaUSD 230.8 MUSD 328.97 M5,212
Online platform offering multiple healthcare services
2013Bengaluru, Karnataka, IndiaUSD 199.22 MUSD 62.4 M52
An online marketplace for healthcare products is operated.
2011Kolkata, West Bengal, IndiaUSD 38.26 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Bookmeds

Premium access

Complete news archive for BookMeds

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BookMeds

BookMeds was founded in 2014.

BookMeds is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

BookMeds is a funded company, having raised a total of $245.28K across 3 funding rounds to date. The company's 1st funding round was a Angel Round of $100K, raised on Dec 2014.

The primary company behind BookMeds, Zibew E-Commerce Services Private Limited, reported revenue of β‚Ή79.9 Lakh for FY 2024, down 18% year on year.

Bookmeds Is An Online Healthcare Start-up That Enables Customers To Order Prescriptive And Non-prescriptive Medicines As Well As Surgical Medical Products. Sources Medicines Products From Local Pharmacies. Employs Certified Pharmacists For All Pharmaceutical-related Operations Including Delivery Of Medicines. Offers Cash On Delivery As Well As Online Payment. Used Especially For Life-saving Medicines That Are Not Easily Available. Invoice For The Medicine Is Generated By The Local Pharmacy In The Name Of The End User. Raised 100,000 (inr 6.3m) In Seed Funding From Fabella Singapore , An Investment Firm Founded By Krish Datta, Former President (southeast Asia And Emerging Markets) At Sap. Providing 30 Odd Deliveries A Day, As Of Dec 2014. Currently Catering To Hyderabad.

BookMeds's top competitors include Tata 1mg, PharmEasy and Truemeds.

BookMeds has 1 investor. Key investors include Fabella Singapore.

The valuation of BookMeds is $4.78M as of Oct 2015.

BookMeds operates through Zibew E-Commerce Services Private Limited.

The legal entities of BookMeds currently have 2 directors, including Kouser Banu, Subathra Santhanam.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available